The “don't eat me” signal CD47 is a novel diagnostic biomarker and potential therapeutic target for diffuse malignant mesothelioma

Diffuse malignant mesothelioma (DMM) is one of the prognostically most discouraging cancers with median survivals of only 12–22 months. Due to its insidious onset and delayed detection, DMM is often at an advanced stage at diagnosis and is considered incurable. Combined chemo- and radiotherapy follo...

Descripción completa

Detalles Bibliográficos
Autores principales: Schürch, Christian M., Forster, Stefan, Brühl, Frido, Yang, Sara H., Felley-Bosco, Emanuela, Hewer, Ekkehard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739575/
https://www.ncbi.nlm.nih.gov/pubmed/29296529
http://dx.doi.org/10.1080/2162402X.2017.1373235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739575/
https://www.ncbi.nlm.nih.gov/pubmed/29296529
http://dx.doi.org/10.1080/2162402X.2017.1373235

Ejemplares similares